Sign in

CIK 0001691082 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

LB PHARMACEUTICALS INC

Sign in to watch
Ticker
LBRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
917-450-6581
Business address
575 MADISON AVENUE, NEW YORK, NY, 10022
Former names
LB PHARMACEUTICALS INC.
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 4 Open-market buy 10% owner bought 2,666,666 shares at $15.00 ($39,999,990)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market buy 10% owner bought 1,000,000 shares at $15.00 ($15,000,000)
  5. 4 Open-market buy Director bought 1,000,000 shares at $15.00 ($15,000,000)
  6. 4 Open-market buy 10% owner bought 333,333 shares at $15.00 ($4,999,995)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 8-K Event Bylaws or fiscal year change
  19. 424B4 Offering Prospectus
  20. 3 Insider Initial Statement of Ownership

Page 5 of 8 · 143 filings